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Abstract 
Choosing the most appropriate treatment for individual patients with low back pain (LBP) 
can be challenging, and clinical guidelines recommend taking into account patients’ 
preferences. However, no tools exist to assess or compare patients’ views about LBP 
treatments. We report the development and validation of the LBP Treatment Beliefs 
Questionnaire (LBP-TBQ) for use across different treatments in clinical practice and 
research. Using qualitative data we developed a pool of items assessing perceived credibility, 
effectiveness, concerns about and individual ‘fit’ of specific treatments. These items were 
included in a survey completed by 429 primary care patients with LBP, of whom 115 
completed it again 1 to 2 weeks later. We performed psychometric analyses using non-
parametric item response theory and classical test theory. The four subscales of the resulting 
16-item LBP-TBQ showed good homogeneity (H=.46-.76), internal consistency (α =.73-.94), 
and stability (r=.63-.83), confirmed most convergent and discriminant validity hypotheses, 
and had acceptable structural validity for four guideline-recommended treatments: pain 
medication, exercise, manual therapy and acupuncture. Participants with stronger positive 
treatment beliefs were more likely to rank that treatment as their first choice, indicating good 
criterion validity (t values=3.11-9.80, all p<.01, except pain medication effectiveness beliefs, 
t(339)=1.35; p=.18). A short 4-item version also displayed good homogeneity (H=.43-.66), 
internal consistency (α=.70-.86), and stability (r=.82-.85), and was significantly related to 
treatment choice (t values=4.33-9.25, all p<.01). The LBP-TBQ can be used to assess 
treatment beliefs in primary care patients with LBP and to investigate the effects of treatment 
beliefs on treatment uptake and adherence.  
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Introduction 
Low back pain (LBP) is a leading cause of disability world-wide [42] and is managed mostly 
within primary care. Most patients have non-specific LBP [1;15] and 75% may continue to 
have pain and/or disability 12 months after the initial consultation [13]. Clinical guidelines 
recommend several treatments, including conventional (e.g. education, exercise, pain 
medication), complementary/alternative (CAMs) (e.g. acupuncture, manual therapy) and 
combined physical and psychological treatments (pain management courses) [1;11;49;50]. 
The clinical challenge is to choose optimal treatments for individuals; clinical guidelines 
explicitly encourage considering patients’ preferences [1;11;49;49;50;50], but offer no 
recommendations on how to elicit and integrate them into decision-making. Clear 
conceptualization and standardized assessment of patients’ preferences would facilitate 
further research and possible subsequent integration into practice.   
Treatment preferences can be understood within the extended Common-Sense Model 
(CSM) of illness representations [33]. This model stipulates that, when confronted with a 
medical problem, patients develop cognitive and emotional representations of their condition 
and beliefs about possible treatments (“treatment beliefs” [26] based on information from 
various sources), which guide their behaviours (e.g., treatment choice) and can predict 
subsequent clinical outcomes (e.g., pain). Significant relationships have been found between 
illness representations, treatment beliefs, and outcomes such as adherence and satisfaction in 
various chronic conditions [7;22;24;27;28;44] including LBP [17;20]. According to the CSM, 
treatment preferences develop when patients attempt to “match” treatments to their condition, 
aiming for coherence between illness representations and treatment beliefs. For example, 
patients who believe their LBP is caused by a mechanical problem may prefer treatments they 
believe can remedy mechanical dysfunctions and choose manual therapy; patients who see 
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LBP as essentially a pain symptom may prefer treatments they consider appropriate to reduce 
pain, and choose pain medication. Reliable and valid measurement of treatment beliefs in 
LBP is needed to further test such hypotheses derived from the CSM and facilitate shared 
decision-making. 
Illness perceptions have been examined extensively: validated questionnaires are 
available [10;41;63] and have been used in LBP research [17;20]. However, we could not 
identify a treatment beliefs questionnaire applicable to different LBP treatments that 
concomitantly assesses several relevant beliefs. Existing measures are treatment-specific 
[9;18;29;34;37;60;62], and previous studies in LBP have focused on single belief dimensions, 
e.g. expectations of effectiveness [19;43;52;58], or perceived credibility [55]. However, 
qualitative research suggests that LBP treatment beliefs are multidimensional [21;25]. In our 
recent qualitative study, patients evaluated LBP treatments according to four specific 
dimensions: perceived credibility, individual fit, concerns, and effectiveness [16]. Here we 
report the development and validation of a questionnaire, the Low Back Pain Treatment 
Beliefs Questionnaire (LBP-TBQ), which assesses patients’ beliefs about four practitioner-
delivered primary care treatments: pain medication, exercise, manual therapy, and 
acupuncture. We focused on these treatments as they are the frontline treatments named in 
the National Institute for Health and Care Excellence (NICE) care pathway for persistent 
non-specific LBP [49;50], and are also recommended by the American College of Physicians 
and the American Pain Society LBP guidelines [9]; pain medication, exercise, and manual 
therapy are also endorsed in European guidelines for chronic non-specific LBP [1]. 
 
Methods 
Instrument Development 
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In our previous qualitative study [16] we showed how 75 patients participating in 13 focus 
groups evaluated specific LBP treatments according to whether they: perceived them to be 
believable and to ‘make sense’ (credibility); expected them to lead to symptom improvements 
(effectiveness); had concerns that treatments might cause further damage or have side-effects 
(concerns); felt the treatment would be a suitable solution for them personally (individual fit). 
Because patients expressed these beliefs about specific treatments (e.g. pain medication, 
acupuncture) we termed these Specific Treatment Beliefs. Themes reflecting the context of 
treatment decision-making also emerged and highlighted the importance of understanding 
patients’ more general treatment-seeking beliefs: their need for a clear diagnosis, their 
willingness to try different treatments, their interest in self-management and their 
expectations regarding the healthcare system [16]. We developed an item pool comprising 71 
items, 27 items assessing the Specific Treatment Beliefs (the focus of this paper) and 44 
assessing the contextual themes (to be reported elsewhere). 
We reviewed our qualitative data to choose item content and wording that reflected 
topics and terminology used by participants. To facilitate comparisons between patients’ 
beliefs about different treatments, items assessing Specific Treatment Beliefs were designed 
to be answered four times, once each in relation to: pain medication, exercise, manual 
therapy, and acupuncture. Therefore, issues specific to particular treatments (e.g. fear of 
needles in acupuncture) were not included. Remaining items were worded more generically 
in order to capture these specific issues (e.g. “I have concerns about [acupuncture] for my 
back pain”).   
We pre-tested the initial pool of 27 items using cognitive “think aloud” interviews 
[64] with 10 adults with LBP. This pre-test allowed us to select the most appropriate items 
for further testing and to adjust item content and wording to enhance face validity and 
acceptability. After the pre-test we retained 20 items on Specific Treatment Beliefs in the 
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Draft LBP-TBQ for psychometric testing. The reasons for exclusion were: 1) participants 
interpreted the item in a different way from the intended meaning (1 item); 2) the item was 
too similar to another item that was perceived as clearer (4 items); 3) the respondents had 
difficulties applying it to all four treatments (1 item); or 4) the item was more related to the 
context of care than to the treatment itself (1 item). We opted for a lower number of items 
and a confirmatory approach to psychometric testing (instead of a higher number of items and 
an exploratory approach) because of the increased patient burden involved in answering 
questions repeatedly for each of the four treatments and to facilitate analysis of the structure 
of the questionnaire across all four treatments. 
 
Design and Procedure 
We included the Draft LBP-TBQ, items on the context of treatment decision-making, several 
validating measures, and questions on demographic and clinical characteristics in a self-
report survey of adults (at least 18 years) with LBP. We included adults who reported LBP 
for at least 6 weeks because our prior qualitative work revealed that, although the NICE 
guidelines particularly focus on persistent non-specific LBP (i.e. pain not caused by 
malignancy, infection, fracture, inflammatory disorders, nerve root compression, and lasting 
between 6 weeks and 12 months), the distinction between persistent and chronic LBP is 
rarely used in practice by clinicians or patients [6;16]. We aimed to examine whether our 
questionnaire applies to all people experiencing LBP for more than 6 weeks, irrespective of 
duration of complaint, whether LBP is non-specific (e.g. report a diagnosis of sciatica, or 
symptoms that can be clinically interpreted as nerve compression), or whether patients are 
treatment-experienced or treatment naïve. Therefore, we did not apply additional exclusion 
criteria but compared responses to our questionnaire across different sub-groups of patients.  
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Participants were recruited between November 2011 and March 2012 from public 
sector primary care physicians (General Practitioners, GPs) and private sector CAM clinics in 
three South England counties (Hampshire, Wiltshire and Dorset), and advertisements on 
online UK-based patient forums. We aimed for 400 participants, a statistically-acceptable 
sample size for our planned psychometric analyses, acknowledging that statistical power also 
depends on data properties that could not be estimated prior to analysis [38;57;65]. 
Physicians and CAM clinicians forwarded paper-based surveys to their eligible patients by 
post. Online advertisements linked directly to an identical web-based survey. To enable 
examination of test-retest reliability, participants were asked to volunteer to complete the 
LBP-TBQ again; all such volunteers were sent a second survey by post or email one week 
later. We obtained ethics approval from Southampton and South West Hampshire REC B 
(10/H0504/78). 
 
Draft Low Back Pain Treatment Beliefs Questionnaire (LBP-TBQ) 
In the 20-item Draft LBP-TBQ, 4 items assessed perceptions of credibility (2 
negatively-worded, i.e. described in terms of doubting the credibility of the treatment), 5 
items assessed perceived effectiveness (2 negatively-worded), 6 items assessed concerns (4 
negatively-worded) and 5 items assessed perceived individual fit (3 negatively-worded) (see 
Table 2 for item content). A 5-point verbal response scale was used for all items (Strongly 
Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree), and scored (1-5) 
such that a high score represented positive beliefs about the LBP treatment. Each set of 20 
items was presented with respect to each of the four treatments – pain medication, exercise, 
manual therapy and acupuncture (so each participant responded to 80 LBP-TBQ items). 
Definitions of these treatments, based on the UK NICE guidelines [49;50], were provided to 
limit variability in interpreting treatment labels and encourage answers that can be interpreted 
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within the context of UK clinical practice; these definitions may need to be adjusted for 
different purposes in future research (subject to confirmation of psychometric properties in 
specific other contexts and populations). 
 
Validating Measures 
We developed hypotheses about relationships between each validating measure and the Draft 
LBP-TBQ subscales (see below and Table 3). In brief, to demonstrate convergent validity, we 
required at least medium or strong significant correlations (i.e., r ≥ 0.3). To demonstrate 
discriminant validity, we required at most small to moderate significant correlations (r < 0.3) 
[12]. Cronbach’s alpha values reported below for the validating measures were all calculated 
in the present sample. 
Beliefs about Medicine Questionnaire (BMQ) - General Beliefs [29]. Respondents 
completed 5-point scales to rate their agreement with statements representing beliefs about 
the potential harmful effects of medicines (BMQ-Harm, 4 items, e.g. ‘medicines do more 
harm than good’, Cronbach’s α = .68 in the present sample) and about medicines being over-
prescribed by doctors (BMQ-Overuse, 4 items, e.g. ‘doctors use too many medicines’, α = 
.76). High scores indicated more negative beliefs about medicines. Both BMQ scales were 
used to assess the convergent validity of the LBP-TBQ Concerns subscale for pain 
medication. 
The Brief Illness Perceptions Questionnaire (BIPQ) [10]. Single items with 11-
point response scales assessed 8 dimensions of illness perceptions: consequences (the extent 
to which LBP affects one’s life), timeline (the expected duration of LBP), personal control 
(the extent to which one perceives control over one’s LBP), treatment control (the extent to 
which one perceives one’s treatment controls one’s LBP), identity (the number of symptoms 
associated with LBP), coherence (the extent to which one understands one’s LBP), concern 
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(the extent of concerns about LBP), emotional response (the extent of emotional distress 
attributed to LBP). We worded all items to refer to ‘your low back pain’ instead of ‘your 
illness.’ Perceptions of causes of LBP were investigated using an adapted version of the 
‘perceptions of illness causes’ subscale of the revised IPQ [41] that requires respondents to 
agree or disagree (on 5-point response scales) that each of 18 factors was a cause of their 
LBP (reliability not applicable as no total scores were computed). We retained existing items 
potentially relevant to patients’ perceptions of the causes of their LBP and replaced other 
items (pollution in the environment; alcohol, smoking; my personality; altered immunity) 
with commonly perceived causes of LBP (malformation of the spine; pregnancy or giving 
birth; wear and tear; a physical problem in my back, e.g. a ‘slipped disc’; a specific disease in 
my back, e.g. osteoporosis), using data from a previous questionnaire-based study [8], our 
qualitative work [16], and our clinical and research experience. The BIPQ concern and 
emotional response items were used to assess the divergent validity of all four LBP-TBQ 
subscales for all four treatments. 
Credibility Expectancy Questionnaire (CEQ) [14]. Two subscales assessed 
perceptions of treatment credibility (CEQ-Credibility, 3 items with 9-point response scales, 
e.g. ‘At this point, how logical does [treatment] seem?’) and outcome expectancy (CEQ-
Expectancy, 1 item with 9-point response scale and 2 items with a 11-point response scale, 
from 0% to 100%, e.g. ‘By the end of a course of [treatment], how much improvement in 
your back pain do you think would occur?’). To reduce response burden, each respondent 
answered the CEQ in relation to one of the four treatments only (randomised allocation). 
Good internal consistency was shown in our sample for credibility (α range .85 - .94) and 
expectancy (α range .85-.96) scales for all treatments. High scores indicated perceiving the 
treatment as more believable, convincing and logical, and as leading to bigger improvements. 
CEQ-Credibility was used to assess the convergent validity of the LBP-TBQ credibility 
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subscale for all four treatments. CEQ-Expectancy was used to assess the convergent validity 
of the LBP-TBQ expectancy subscale for all four treatments. 
Holistic Complementary and Alternative Medicine Questionnaire (HCAMQ) 
[31] Attitudes to CAM subscale. Six statements assessed general attitudes towards CAM 
using 6-point agree/disagree response scales (e.g. ‘It is worthwhile trying complementary 
medicine before going to the doctor’, α = .71). High scores indicated stronger beliefs that 
CAM is ineffective and unscientific compared to mainstream medicine. The HCAMQ 
Attitudes to CAM subscale was used to assess the convergent validity of all four LBP-TBQ 
subscales for manual therapy and acupuncture. 
Tampa Scale of Kinesiophobia (TSK-11) Activity Avoidance subscale [48]. Six 
items assessed beliefs about the relationship between movement, pain and re-injury (TSK-
Activity Avoidance, e.g. ‘I’m afraid I might injure myself if I exercise’, α = .81) using 4-
point agree-disagree response scales. High scores indicated more intense concerns and beliefs 
that movement leads to (re)-injury and should therefore be avoided. The TSK-Activity 
Avoidance subscale was used to assess the convergent validity of the LBP-TBQ concerns 
subscale for exercise. 
Treatment ranking. To assess criterion validity, participants were asked to rank the 
four treatments (pain medication, exercise, manual therapy, acupuncture) in order of 
preference starting with the treatment they would most like to have. Choices regarding each 
treatment were coded separately and dichotomised to identify two groups of patients for each 
treatment: those who did and those who did not select that treatment as their first choice. We 
hypothesised that scores on the LBP-TBQ subscales would distinguish between these two 
groups of patients for each treatment.   
 
Participants’ Demographic and Clinical Characteristics   
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We used single items to assess socio-demographic characteristics (age, gender, education 
level, employment status, ethnicity) and clinical characteristics (duration of LBP, 
previous/current use of various treatments for LBP and satisfaction with these treatments, 
self-reported co-morbidities including sciatica, receiving benefits for LBP, perception of 
general health status).   
LBP severity over the past 6 months was assessed with the Chronic Pain Grade 
Questionnaire [61] which comprises 3 pain intensity items (present, worst, and average) and 
4 disability items (number of days kept from usual activities, and pain interference with daily 
activities, recreational or social activities, and work). Responses were used to compute 5 pain 
grades, from no pain and disability through to highest disability irrespective of pain intensity 
[56]. Participants who had experienced LBP in the past year (single item), were asked 
whether they currently experience pain and whether they had experienced 3 symptoms 
suggestive of a differential diagnosis of nerve root compression: leg pain worse than back 
pain, leg pain worse when coughing or sneezing, and numbness or pins and needles in the leg 
or feet. Participants who reported any of these symptoms were classified as more likely to 
have nerve root compression. 
 
Data Analysis 
Data analysis was performed in SPSS Statistics 21 (IBM Corp. Released 2012. IBM SPSS 
Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.), AMOS 21 [2] and R 
[mokken package; 3;4;47]. Data entry was checked for accuracy. We identified no systematic 
pattern of missing data for the selected variables (Little’s MCAR test; χ2 (36655) = 36771.69, 
p =.33). Missing data were computed via expectation maximization for the relevant 
questionnaire items (excluding items where non-completion was expected based on responses 
to previous items). We computed descriptive statistics for demographics, clinical data, and 
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validation measures. We performed psychometric analyses separately for the specific and 
general treatment beliefs items. 
Item selection and structural validity. We used a confirmatory approach to 
questionnaire validation and aimed for a final item set that included an optimal, 
parsimonious, number of items that would permit the use of both sum scores and individual 
items in latent variable models (i.e. 4 items per construct, of which 2 should be negatively-
worded). We examined the structure of the item sets on the first-wave dataset using non-
parametric item response theory (NIRT), i.e. Mokken Scale Analysis (MSA) 
[23;39;40;53;54;59]. According to MSA, items order respondents stochastically on one latent 
dimension representing the target construct if they meet three criteria: 1. unidimensionality 
(i.e. respondents that endorse more intense items are also more likely to endorse less intense 
items, while endorsing less intense items is not related to the probability of endorsing more 
intense items), 2. local independence (i.e. the statistical relationship between items should be 
explained solely by the latent construct), and 3. latent monotonicity (i.e. the probability of 
endorsing an item should not decrease with increasing levels of the latent construct). We 
investigated these properties by calculating coefficients of homogeneity (H) at item, item-
pair, subscale, and scale level. Homogeneity values range from 0 (no association) to 1 
(perfect association given differences in item intensity), where .3-.4 indicates weak, .4-.5 
medium, and values over .5 good homogeneity. To reduce scale length, items presenting low 
homogeneity and violations of latent monotonicity were considered for exclusion. We 
subsequently examined correlations between the resulting subscales.  
We further investigated structural validity using confirmatory factor analyses (CFA), 
since MSA is nonparametric and therefore does not allow modelling the effect of using 
positively- and negatively-worded items. Models were evaluated in relation to established 
criteria for the likelihood ratio χ2 test, incremental fit and residual-based indices (TLI and 
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CFI>.95; RMSEA and χ2 p value <.05) [30;32]. We followed recommendations to judge 
model fit flexibly within the broader context of model diagnosis and theory and to consider 
fit criteria alongside overall model tenability and possible sources of misspecification 
[35;36]. 
To investigate alternative structures, we used an automated item selection procedure 
(aisp) to group items into Mokken scales in a data-driven manner and identify un-scalable 
items at increasing homogeneity threshold values (Hemker et al 1995).  
Reliability. The new subscales were also examined according to classical test theory. 
Internal consistency was assessed via Cronbach’s alpha (above .70), item-total correlations, 
and Cronbach’s alpha if item excluded. Correlations between responses to the same scales at 
first and second survey administration were used to judge test-retest reliability over 1-2 
weeks based on a threshold of r=.70 [45]. 
Convergent and discriminant validity. The subscales were tested for convergent 
and discriminant validity against existing measures using Pearson’s correlations (sensitivity 
analyses were performed with Spearman’s ρ and Kendall’s τ, to account for the ordinal level 
of some measures).   
Criterion validity. The new LBP-TBQ subscales were examined against treatment 
ranking reports to assess their ability to predict treatment preferences. We used t-tests to 
compare scores between participants who did and did not rank each treatment as their first 
choice.   
Measurement invariance (MI). Multi-group CFA analyses were performed to 
investigate whether different subgroups of respondents attribute the same meaning to the 
target construct (metric invariance) and whether respondents with equal scores on the latent 
construct also have equal scores on the items (scalar invariance). If a scale has these 
properties, then group differences in mean scores can be interpreted as substantive 
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differences as they are not due to participants in different groups attributing different 
meanings to the scale, or to measurement bias of individual items in these groups [51]. Five 
comparisons were considered: respondents with nerve root compression likely or unlikely 
(based on self-reported presence of one or more of three indicative symptoms); respondents 
that self-reported sciatica diagnosed in relation to LBP or not; respondents with or without 
experience of each treatment; and the two data collection waves. 
Selection and validation of the short-form LBP-TBQ. To increase the feasibility of 
using the LBP-TBQ in multi-measure patient surveys and fast-paced clinical contexts, we 
developed a short 4-item LBP-TBQ version by selecting one best performing item (i.e. higher 
homogeneity and lower Cronbach α if-item-excluded, for all treatments) for each dimension 
of treatment beliefs. We examined homogeneity, internal consistency, stability, and criterion 
validity of this scale following the procedures described above. 
 
Results 
Participants 
The survey was completed by 429 participants, of whom 344 (80%) responded to the 1498 
invitations mailed to public sector physicians’ patients (23% response rate). Participants were 
aged 18 to 90 years (M = 55; SD = 15.2); 247 (60%) were women and 393 (91.6%) were of 
British, Irish or other white ethnic background. The majority (335; 78.1%) completed the 
paper-version. Participants reported having LBP for between 6 weeks and 52 years (median 6 
years; interquartile range 13.18 years); 415 (96%) had LBP in the past year, 400 (93.2%) in 
the past 6 months, and 308 (71.8%) at the time of the survey; 398 (92.8%) considered their 
general health to be ‘fair’ to ‘very good’, but more than half reported high disability (i.e. 
chronic pain grade III or IV). Only 61 (15.5%) reported receiving state benefits for LBP. Of 
the 174 volunteering to complete the survey twice, 115 (66.1%) participants completed and 
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returned the LBP-TBQ again 1-2 weeks later. There were no differences between respondents 
and non-respondents to the second survey in age, gender, pain duration, general health levels, 
pain intensity, disability levels, or chronic pain grade. Additional socio-demographic and 
clinical data and descriptive statistics for the validating measures are available in Table 1 and 
Supplementary Digital Content 1 (available online at http://links.lww.com/PAIN/A79).   
 
Insert Table 1 Here  
 
Item selection and structural validity 
Items were selected iteratively based on homogeneity and monotonicity results at item, item-
pair, and scale level for all four treatments. Four items were excluded based on item 
properties and content  to achieve four 4-item subscales with two reversed items each and 
good homogeneity and monotonicity, except three significant violations of monotonicity for 
Acupuncture items (Table 2; see also Supplementary Digital Content 2 which shows initial 
homogeneity values for all items and the violations of monotonicity for acupuncture items 
[available online at http://links.lww.com/PAIN/A80]).  
 
Insert Table 2 Here  
 
We examined structural validity via CFA for each treatment by comparing the 
hypothesized 4-factor model (covariance between factors and covariances between error 
terms of reverse-coded items) with several alternatives (1-factor model, 4-factor model with 1 
common higher-order factor, 1-factor model improved via specifying error covariances 
suggested by modification indices). Although none of the models reached threshold values 
for all fit indices and all treatment types, the 4-factor model performed slightly better than its 
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alternatives. As an example, Figure 1 displays model parameter estimates for pain medication 
items. (Supplementary Digital Content 3 shows parameter estimates and model fit for 
alternative models and other treatment types [available online at 
http://links.lww.com/PAIN/A81].) 
 
Insert Figure 1 Here  
 
Reliability. All four subscales showed acceptable internal consistency, with 
Cronbach’s α values ranging from .73 to .94. They also showed acceptable test-retest 
validity: over 1-2 weeks pain medication effectiveness exhibited the lowest stability (r=.63), 
and manual therapy concerns exhibited the highest stability (r=.83). For details see Table 3. 
 
Insert Table 3 Here  
 
Convergent and discriminant validity 
As hypothesized, on the whole the LBP-TBQ subscales were at least moderately associated 
with conceptually-related constructs (r>.3), and showed medium to non-significant 
associations (r<.3) with constructs expected to be conceptually different (Table 4). The main 
exceptions involved the discriminant validity of the exercise subscales which unexpectedly 
correlated with LBP perceptions (BIPQ): exercise concerns and exercise individual fit were 
moderately correlated with LBP concerns; and exercise concerns were moderately correlated 
with perceived emotional impact of LBP. Related to convergent validity, the observed 
correlations of 0.29 fell just short of the hypothesized 0.3 between attitudes to CAM 
(HCAMQ) and beliefs regarding effectiveness and individual fit of manual therapy, and 
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between general beliefs about the harmful effects of medications (BMQ) and LBP-specific 
medication concerns.  
 
Insert Table 4 Here  
 
Criterion Validity 
For each treatment, those participants who ranked a treatment as their top choice had more 
positive beliefs about that treatment than did other participants. This difference was 
significant for all treatments and all subscales, except beliefs about the Effectiveness of Pain 
Medication (Table 5). In other words, when participants had stronger beliefs about a 
treatment’s effectiveness, credibility, and individual fit, and had fewer concerns about a 
treatment, they were more likely to prefer that treatment.  
 
An Alternative Structure 
Subscale scores were highly correlated with each other within treatments (shown in 
Supplementary Digital Content 4, available online at http://links.lww.com/PAIN/A82). An 
exploratory MSA (aisp; results shown in Supplementary Digital Content 5, available online at 
http://links.lww.com/PAIN/A83) revealed that the entire item set could alternatively be 
considered a single 16-item scale with medium to good homogeneity. For this global scale, 
homogeneity scores were .46, .59, .60, .67 and Cronbach’s α values were .92, .95, .95, and 
.96 for pain medication, acupuncture, exercise and manual therapy respectively. 
 
Insert Table 5 Here  
 
Measurement Invariance 
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Multi-group CFA analyses (summarised in Table 6) indicated that all scales showed scalar 
invariance between the two data collection waves and in most other subgroup comparisons, 
with some exceptions. Manual Therapy Beliefs displayed metric invariance between 
subgroups differentiated on probability of nerve root compression and self-reported sciatica 
diagnoses (results shown in Supplementary Digital Content 6, available online at 
http://links.lww.com/PAIN/A84). Exercise Beliefs displayed metric invariance between 
treatment experience subgroups (results shown in Supplementary Digital Content 7, available 
online at http://links.lww.com/PAIN/A85). No measurement invariance was observed for 
Medication Beliefs between patients with and without nerve compression (results shown in 
Supplementary Digital Content 8, available online at http://links.lww.com/PAIN/A86). No 
measurement invariance was observed for Acupuncture Beliefs in patients with or without 
sciatica and with or without treatment experience (results shown in Supplementary Digital 
Content 9, available online at http://links.lww.com/PAIN/A87). In addition, no measurement 
invariance was found between medication, exercise, manual therapy and acupuncture 
regarding the LBP-TBQ scales (results shown in Supplementary Digital Content 10, available 
online at http://links.lww.com/PAIN/A88). 
 
Insert Table 6 Here  
 
Short Version of the LBP-TBQ  
One item was selected to represent each subscale based on scores on homogeneity and 
Cronbach’s α if item excluded (the item with best properties for all treatments). The 4-item 
version of the questionnaire displayed good homogeneity (H=.43-.66) (Table 7), internal 
consistency (α=.70-.86), and stability (r=.82-.85) (Table 8). People that ranked a treatment as 
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their first choice reported significantly more positive treatment beliefs than people that 
ranked the treatment as a second, third or last option (Table 9).  
 
Insert Table 7 Here  
Insert Table 8 Here  
Insert Table 9 Here  
 
Discussion 
To facilitate the integration of treatment preferences in LBP clinical decision-making in 
primary care and to stimulate further research on this topic, we developed and validated a 16-
item scale to measure core beliefs about four recommended LBP treatments (pain medication, 
exercise, manual therapy, acupuncture). The newly-developed LBP-TBQ showed good item 
properties, homogeneity, internal consistency, and stability. Discriminant and convergent 
validity were confirmed for most treatments, and the 4-factor structure was largely 
confirmed. Participants were more likely to rank a treatment as their first choice if they had 
stronger beliefs about its effectiveness, credibility, and individual fit, and fewer concerns 
about it, thus supporting the LBP-TBQ’s criterion validity. A short 4-item LBP-TBQ was 
also developed with best-performing items and showed good psychometric properties. Both 
16-item and 4-item versions (available in Supplementary Digital Content 11 available online 
at http://links.lww.com/PAIN/A89) can be used in future research and clinical practice to 
assess patients’ beliefs about treatments.  
The LBP-TBQ has several strengths compared to previous treatment belief 
questionnaires. First, our scale addresses several LBP beliefs in relatively compact 16-item or 
4-item formats applicable to one or more treatments. This allows a comprehensive 
assessment with relatively low participation burden compared to existing scales, which assess 
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selected dimensions (e.g. overuse and harm in the 8-item BMQ [29], credibility and outcome 
expectancies in the 6-item CEQ [14]) and would need to be combined in a longer 
questionnaire without covering all relevant dimensions (e.g. individual fit). Second, previous 
scales are treatment specific. For example, deciding on medication use was previously 
described as involving a cost-benefit analysis comparing perceived benefits to concerns [27], 
while for other treatments perceived credibility and expected results have been considered 
more relevant [14]. In the LBP-TBQ, identical items assess beliefs about several treatments, 
facilitating direct comparisons. Third, the LBP-TBQ takes into account acquiescence bias by 
including negatively-worded items, which is rarely considered. For example, medication 
necessity and concerns have previously emerged as separate dimensions, but distinctions may 
be partly due to item wording [29]. Fourth, using NIRT methods allowed us to account for 
item difficulty and identify latent constructs under less strict (and more realistic) assumptions 
than parametric IRT [59]. And fifth, exploring measurement invariance enabled in-depth 
understanding of possible sources of variance in questionnaire structure and highlighted areas 
for improvement.  
The LBP-TBQ benefits from combining theory and empirical qualitative data. 
Theoretically, it conceptualizes patients’ preferences within the CSM as developing from 
patients’ illness and treatment perceptions [26], and therefore assesses patients’ beliefs about 
treatments to provide information relevant for clinical decision-making. According to the 
CSM (and confirmed in our qualitative research [16]), patients need to form adequate illness 
representations (e.g. illness identity and causal representations) to inform their treatment 
decisions; thus future studies should assess illness representations alongside treatment beliefs. 
By using empirical qualitative data, we were able to construct items based on the language 
LBP patients use to describe their beliefs.  
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Our validation study also revealed unanticipated and interesting differences between 
how patients perceive LBP treatments. First, contrary to our hypotheses, we identified 
significant moderate associations between patients’ concerns and perceptions of individual fit 
regarding exercise and their concerns about, and emotional representations of, LBP. These 
associations suggest that, unlike other (arguably more passive) treatments, patients with 
fewer LBP concerns and less intense emotions about LBP have fewer concerns about 
exercise and stronger beliefs that exercise is right for them. Second, effectiveness beliefs 
showed the weakest stability, particularly for medication (r=.63-.76), suggesting that 
effectiveness beliefs fluctuate more over time than others. It may be that these beliefs are 
more easily influenced (e.g. by personal or vicarious experience of medications or 
practitioners) than beliefs about credibility, concerns, and individual fit Understanding the 
causes and mechanisms of belief variability may be a promising avenue for further research 
and may reveal appropriate approaches to influencing the development of treatment beliefs. 
Third, measurement invariance was not achieved between treatments, suggesting that patients 
may interpret items and constructs somewhat differently when assessing different treatments. 
This is expected given differences between treatments (e.g. one’s concerns regarding 
medication can be very different to those about exercise) and suggests that future research 
using the LBP-TBQ for treatment comparisons should first identify the sources of these 
differences and establish partial invariance. 
The measurement invariance findings prompt specific recommendations regarding 
future applications and development of the LBP-TBQ. Scalar invariance was achieved for all 
treatments between data collection waves and pain duration subgroups, supporting the use of 
the LBP-TBQ in longitudinal studies, or to compare groups of patients experiencing pain for 
less or more than 3 years. Not all treatments displayed scalar invariance between patients 
with different probability of nerve root compression, self-reported sciatica, or treatment 
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experience; patients in these subgroups might attribute different meanings to particular items 
or constructs. Therefore, the LBP-TBQ structure would benefit from further investigation in 
relation to different patient characteristics. We recommend researchers using the LBP-TBQ 
for subgroup comparisons first ascertain whether these subgroups interpret questionnaire 
items similarly, by performing measurement invariance analyses before examining group 
differences or using cognitive interviews. Moreover, further psychometric work is needed 
before using the LBP-TBQ to assess beliefs about other treatments (e.g. cognitive-behavioral 
therapy, multidisciplinary rehabilitation), or in other populations, languages or settings, and 
we recommend additional qualitative and psychometric examinations of its relevance and 
item properties in new contexts [5]. 
Our research is subject to several limitations. First, our participants were recruited 
from patients consulting with their primary care GP or CAM practitioner; results might be 
different in secondary care patients (e.g. those who are undergoing hospital-based treatments 
or being considered for spinal injections or surgery). However, some of our patients had 
experienced hospital-based interventions (e.g. 17% had previously attended a pain 
management clinic, see Supplementary Digital Content 1). Second, our participants were 
older and more reported unemployment (mostly retired) and chronic pain compared to other 
primary care LBP samples (e.g. mean age 44 years, 24.6% unemployed (including retirees), 
11.4% with pain duration longer than 3 years in another UK-based primary care cohort [17] 
vs 55 years, 52.5% unemployed (including retirees), and 64.8% with pain for longer than 3 
years in our cohort). This is likely due to differences in participant selection (we contacted all 
LBP patients, not only patients currently consulting their primary care physician) or 
respondent burden (longer survey in the present study). Thus, the properties of the LBP-TBQ 
would benefit from confirmation in other samples. Third, although the 4-factor CFA model 
showed acceptable fit, the subscales were also highly inter-correlated within each treatment 
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and could alternatively be merged into a single “treatment acceptability” dimension. These 
strong associations could be seen as contrasting with our previous qualitative findings where 
they emerged as distinct aspects considered when making treatment decisions [16] and may 
reflect the different socio-cognitive processes involved in questionnaire response versus 
group discussion. Further psychometric work should explore the value of a 4-factor versus 1-
factor structure, as well as measurement invariance and validity in different populations. 
Fourth, our study was informed primarily by the NICE care pathway and thus focused on four 
frontline treatments in the UK; future studies and applications would need to consider local 
availability and clinical relevance when restricting or expanding this selection.  
Our study shows that the LBP-TBQ can be used to assess the beliefs of LBP patients 
regarding four guideline-recommended treatment options (pain medication, exercise, manual 
therapy, acupuncture). According to the extended CSM of illness representations [33], such 
beliefs are likely to be key modifiable determinants of treatment uptake and adherence. 
Understanding these beliefs and behaviours in LBP could allow us to develop interventions to 
optimize the use of evidence-based recommended treatments, and thus improve treatment 
effectiveness and patient outcomes in LBP.  Protocols could be developed for clinicians to 
use the LBP-TBQ to match patients to treatments consistent with their treatment beliefs [e.g. 
46] or to identify and address patients’ negative beliefs about treatments. For example, 
patients could complete the 4-item LBP-TBQ before (e.g. electronically) or during 
consultations (e.g. as a clinical interview) regarding locally-available treatment options. The 
patients’ answers could highlight topics for clinicians to explore in the consultation, perhaps 
after receiving appropriate training: for example, if a patient reports concerns about the 
clinically-preferred treatment the clinician could discuss these openly before agreeing on a 
treatment course. While a less focused discussion of treatment options might be inconclusive, 
completing the LBP-TBQ could help patients crystallise their beliefs and thus prompt a 
AC
CE
PT
ED
  Copyright  2015 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
24 
 
clinically-appropriate decision that reflects patients’ beliefs where possible. Further research 
is needed to develop and test such clinical applications of the LBP-TBQ. 
We recommend the LBP-TBQ for prospective research examining determinants of 
treatment uptake and adherence in patients with LBP. Because it can assess the same beliefs 
about different treatments, the LBP-TBQ can also be used to model treatment choices within 
a more complex decision space than is often considered, i.e. one in which patients are 
choosing one from among many treatment options. Further research could explore clinical 
applications of the LBP-TBQ (particularly its 4-item version) to involve patients in treatment 
decision-making and thus help to more systematically take patients’ preferences into account 
when choosing treatments for LBP [49;50].   
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Figure Captions 
 
Figure 1. CFA Model of the Final LBP-TBQ (Pain Medication items, wave 1, maximum 
likelihood estimation).  
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Table 1. Sample characteristics (N=429) 
Characteristic N (%)a 
Education  
Secondary school or less 183 (42.7%) 
Sixth form-college 107 (24.9%) 
Undergraduate study 75 (17.5%) 
Postgraduate study 34 (7.9%) 
Work status  
Employed  179 (41.7%) 
…at usual job 152 (35.4%) 
…on light duty  16 (3.7%) 
…paid leave or sick leave  8 (1.9%) 
…unpaid leave  3 (0.7%) 
Retired  134 (31.2%) 
Unemployed 230 (21.3%) 
…because of LBP 25 (5.8%) 
…on disability  22 (5.1%) 
…homemaker  27 (6.3%) 
…student  9 (2.1%) 
…for other reasons  13 (3.0%) 
Pain duration (3 categories)  
Persistent LBP (6 wks – 12 months) 88 (20.5%) 
Chronic/recurrent LBP (12 months – 3 years) 63 (14.7%) 
Chronic/recurrent LBP (>3yrs) 278 (64.8%) 
Chronic Pain Grade  
Grade I – low disability, low intensity 82 (19.1%) 
Grade II – low disability, high intensity 90 (21%) 
Grade III – high disability, moderately limiting 81 (18.9%) 
Grade IV – high disability, severely limiting 147 (34.3%) 
Reporting one or more comorbidities 282 (65.7%) 
Subgroups Examined for Measurement Invariance  
Pain duration <3 years 151 (35.2%) 
Self-reported Sciatica 192 (44.8%) 
At least 1 symptom of nerve root compression  144 (33.6%) 
Past Experience of Medication 208 (48.5) 
Past Experience of Manual therapy 273 (63.6) 
Past Experience of Exercise 187 (43.6) 
Past Experience of Acupuncture 127 (29.6) 
a
 Note: Percentages reported without including missing values AC
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Table 2. LBP-TBQ Scale and Item Homogeneity for 4-Item Scales 
 
Content H (SE) 
 Pain 
medication 
Exercise Manual 
therapy 
Acupuncture 
Credibility 0.51 (0.04) 0.67 (0.03) 0.69 (0.03) 0.67 (0.04) 
Taking/Having […] for back pain 
makes a lot of sense 
0.53 (0.04) 0.70 (0.03) 0.71 (0.03) 0.68 (0.04) 
Generally, […] is a believable 
therapy for back pain 
0.53 (0.04) 0.67 (0.04) 0.72 (0.04) 0. 71 (0.04) 
I am sceptical about […] as a 
treatment for back pain in general  
(r) 
0.52 (0.05) 0.66 (0.04) 0.68 (0.04) 0.62 (0.05) 
I do not understand how […] 
could help people with back pain  
(r) 
0.46 (0.05) 0.66 (0.04) 0.65 (0.04) 0.67 (0.04) 
Effectiveness 0.57 (0.04) 0.63 (0.03) 0.74 (0.03) 0.72 (0.04) 
[…] cannot help people with 
back pain  (r) 
0.58 (0.05) 0.61 (0.05) 0.72 (0.04) 0.75 (0.04) 
[…] can work well for people 
with back pain 
0.56 (0.05) 0.61 (0.05) 0.79 (0.03) 0.70 (0.05) 
I think […] is pretty useless for 
people with back pain (r) 
0.60 (0.04) 0.65 (0.04) 0.76 (0.03) 0.72 (0.05) 
[…] can make it easier for people 
to cope with back pain  
0.54 (0.05) 0.66 (0.04) 0.70 (0.04) 0.73 (0.05) 
Concerns 0.46 (0.04) 0.62 (0.03) 0.48 (0.03) 0.64 (0.04) 
I worry that […] could make my 
back worse  (r) 
0.35 (0.04) 0.61 (0.04) 0.60 (0.03) 0.62 (0.04) 
I have concerns about 
taking/having […] for my back 
pain (r) 
0.51 (0.04) 0.68 (0.03) 0.59 (0.03) 0.69 (0.03) 
I would feel at ease about 
taking/having […] for my back 
pain 
0.50 (0.04) 0.64 (0.04) 0.58 (0.03) 0.62 (0.04) 
I feel that […] would not harm 
me 
0.48 (0.04) 0.55 (0.05) 0.52 (0.03) 0.60 (0.05) 
Individual fit 0.69 (0.03) 0.76 (0.03) 0.85 (0.02) 0.71 (0.04) 
I think […] could suit me as a 
treatment for my back pain 
0.68 (0.03) 0.74 (0.03) 0.84 (0.03) 0.72 (0.04) 
For me, taking/having […] would 
be a waste of time (r) 
0.70 (0.04) 0.77 (0.03) 0.87 (0.02) 0.73 (0.04) 
I am confident […] would be a 
suitable treatment for my back 
pain 
0.69 (0.03) 0.77 (0.03) 0.86 (0.02) 0.74 (0.04) 
Given what I know about my 
back pain, I doubt […] would be 
right for me (r) 
0.68 (0.03) 0.75 (0.03) 0.83 (0.03) 0.66 (0.05) 
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Note: Higher scores represent better homogeneity. Italic font is used for items with violations 
of monotonicity, bold font represents significant violations (at default rest group minsize). 
Items excluded during these analyses:  […] can help people with back pain to get on with 
their lives; I think I would find it unpleasant to take/have […] for my back pain (r); I am 
worried that I cannot afford to pay for […] (r); I think […] would not work for my back pain 
(r) 
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Table 3. LBP-TBQ Subscales Means (M), Standard Deviations (SD), Stability and Cronbach α 
 Pain Medication Exercise Manual Therapy Acupuncture 
Scale/Item M(SD) αa Test-
retest 
M(SD) αa Test-
retest 
M(SD) αa Test-
retest 
M(SD) αa Test-
retest 
Credibility 3.60 (0.74) .77  .72 3.81 (0.74) 87  .71 3.62 (0.83) .88  .79 3.17 (0.81) .87  .78 
Taking/Having […] for 
back pain makes a lot of 
sense 
3.75 (0.91) .70  3.86 (0.88) .81  3.67 (0.92) .83  3.21 (0.90) .82  
Generally, […] is a 
believable therapy for back 
pain 
3.53 (0.90) .71  3.82 (0.85) .83  3.70 (0.89) .83  3.30 (0.87) .81  
I am sceptical about […] as 
a treatment for back pain in 
general (r) 
3.35 (1.04) .71  3.68 (0.98) .85  3.50 (1.02) .86  3.10 (1.04) .85  
I do not understand how 
[…] could help people with 
back pain (r) 
3.77 (0.97) .75  3.87 (0.97) .83  3.59 (1.02) .87  3.08 (1.03) .82  
Effectiveness 3.94 (0.71) .81  .63 3.89 (0.72) .85  .69 3.80 (0.75) .90  .70 3.42 (0.68) .89  .76 
[…] cannot help people 
with back pain (r) 
4.01 (0.93) .74  3.99 (0.91) .82  3.82 (0.88) .89  3.50 (0.80) .85  
[…] can work well for 
people with back pain 
3.74 (0.90) .77  3.80 (0.84) .82  3.76 (0.83) .86  3.36 (0.75) .87  
I think […] is pretty useless 
for people with back pain 
(r) 
3.98 (0.96) .72  3.99 (0.91) .80  3.86 (0.87) .86  3.43 (0.82) .87  
[…] can make it easier for 
people to cope with back 
pain  
4.03 (0.79) .79  3.77 (0.82) .79  3.77 (0.82) .90  3.39 (0.76) .86  
Concerns 3.48(0.79) .73  .80 3.32 (0.91) .85  .77 3.33 (0.94) .89  .83 3.36 (0.81) .85  .80 
I worry that […] could 
make my back worse  (r) 
3.86 (0.96) .75  3.15 (1.16) .81  3.15 (1.13) .85  3.40 (0.95) .81  
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I have concerns about 
taking/having […] for my 
back pain (r) 
3.25 (1.21) .62  3.22 (1.15) .76  3.23 (1.17) .85  3.20 (1.06) .76  
I would feel at ease about 
taking/having […] for my 
back pain 
3.52 (1.02) .64  3.48 (1.06) .79  3.49 (1.04) .85  3.26 (1.05) .81  
I feel that […] would not 
harm me 
3.28 (0.99) .66  3.44 (1.01) .84  3.47 (0.98) .88  3.58 (0.83) .83  
Individual Fit 3.51 (0.85) .87  .77 3.56 (0.91) .91  .82 3.40 (0.98) .94   .82 3.05 (0.85) .89  .80 
I think […] could suit me as 
a treatment for my back 
pain 
3.33 (1.01) .83  3.51 (0.98) .88  3.43 (0.99) .93  3.07 (0.92) .85  
For me, taking/having […] 
would be a waste of time (r) 
3.85 (0.96) .84  3.77 (0.99) .88  3.51 (1.05) .92  3.17 (1.02) .85  
I am confident […] would 
be a suitable treatment for 
my back pain 
3.34 (0.98) .83  3.45 (1.02) .87  3.30 (1.06) .92  2.94 (0.95) .84  
Given what I know about 
my back pain, I doubt […] 
would be right for me (r) 
3.52 (1.04) .84  3.49 (1.11) .88  3.37 (1.13) .93  3.02 (1.03) .88  
a
 Cronbach α reported at scale level and item level (if item excluded); higher scores represent better internal consistency.  
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Table 4. Convergent and Discriminant Validity for each Treatment Version of the LBP-TBQ Subscales 
Treatment Version 
Subscale Pain Medication Exercise Manual Therapy Acupuncture 
 Hypothesis Pearson’s r Hypothesis Pearson’s r Hypothesis Pearson’s r Hypothesis Pearson’s r 
         
Credibility  CEQ 
Credibility 
.44**  CEQ 
Credibility 
.66**  CEQ 
Credibility 
.67**  CEQ 
Credibility 
.68** 
 = BIPQ 
Concerns 
-.05 = BIPQ 
Concerns 
-.29** = BIPQ 
Concerns 
-.22** = BIPQ 
Concerns 
.02 
 = BIPQ 
Emotions 
-.06 = BIPQ 
Emotions 
-.24** = BIPQ 
Emotions 
-.18** = BIPQ 
Emotions 
-.02 
      HCAMQ 
Attitudes 
-.32**  HCAMQ 
Attitudes 
-.38** 
         
Effectiveness  CEQ 
Expectancy 
.48**  CEQ 
Expectancy 
.59**  CEQ 
Expectancy 
53**  CEQ 
Expectancy 
.50** 
 = BIPQ 
Concerns 
-.15** = BIPQ 
Concerns 
-.27** = BIPQ 
Concerns 
-.24** = BIPQ 
Concerns 
-.03 
 = BIPQ 
Emotions 
-.13** = BIPQ 
Emotions 
-.22** = BIPQ 
Emotions 
-.19** = BIPQ 
Emotions 
-.05 
      HCAMQ 
Attitudes 
-.29**  HCAMQ 
Attitudes 
-.36** 
         
(Fewer) 
Concerns 
 BMQ 
Harm 
-.29**  TSK 
Activity 
Avoidance 
-.60**  HCAMQ 
Attitudes 
-.32**  HCAMQ 
Attitudes 
-.35** 
  BMQ 
Overuse 
-.39** = BIPQ 
Concerns 
-.39** = BIPQ 
Concerns 
-.24** = BIPQ 
Concerns 
-.06 
 = BIPQ -.10* = BIPQ -.38** = BIPQ -.27** = BIPQ -.10* 
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Concerns Emotions Emotions Emotions 
 = BIPQ 
Emotions 
-.11*       
         
Individual 
Fit 
= BIPQ 
Concerns 
-.04 = BIPQ 
Concerns 
-.32**  HCAMQ 
Attitudes 
-.29**  HCAMQ 
Attitudes 
-.31** 
 = BIPQ 
Emotions 
-.06 = BIPQ 
Emotions 
-.27** = BIPQ 
Concerns 
-.23** = BIPQ 
Concerns 
-.04 
     = BIPQ 
Emotions 
-.23** = BIPQ 
Emotions 
-.05 
Note.   at least moderate positive correlation hypothesised (convergent validity; r ≥ 0.3).   at least moderate negative correlation 
hypothesised (convergent validity; r ≥ 0.3). = at most moderate correlation hypothesised (divergent validity; r < 0.3). 
* p<.05  ** p<.01. 
Abbreviations: BIPQ = Brief Illness Perceptions Questionnaire; BMQ = Beliefs about Medicine Questionnaire; CEQ = Credibility Expectancy 
Questionnaire; HCAMQ = Holistic Complementary and Alternative Medicine Questionnaire; TSK = Tampa Scale of Kinesiophobia. 
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Table 5.  Criterion Validity of LBP-TBQ Subscales 
 Group 1:  Treatment Ranked 1 Group 2: Treatment Ranked 2-4 Between-Group Comparison 
Scale M SD n M SD n t df p 
          
Pain Medication           
 Credibility 3.88 .60 152 3.47 .79 189 -5.44 a 337.8 <.001 
 Effectiveness 4.05 .70 152 3.94 .72 189 -1.35 339 .177 
 (Fewer) Concerns 3.74 .68 152 3.30 .82 189 -5.29 339 <.001 
 Individual Fit 3.82 .70 152 3.32 .89 189 -5.87 a 338.8 <.001 
   
 
  
    
Exercise          
 Credibility 4.24 .56 88 3.75 .81 239 -6.22 a 223.3 <.001 
 Effectiveness 4.27 .58 88 3.84 .71 239 -6.05 325 <.001 
 (Fewer) Concerns 3.73 .82 88 3.19 .90 239 -4.94 325 <.001 
 Individual Fit 4.07 .62 88 3.46 .94 239 -6.84 a 233.1 <.001 
   
 
  
    
Manual Therapy          
 Credibility 4.14 .72 89 3.44 .78 240 -7.34 327 <.001 
 Effectiveness 4.24 .63 89 3.68 .72 240 -6.50 327 <.001 
 (Fewer) Concerns 3.98 .79 89 3.09 .89 240 -8.34 327 <.001 
 Individual Fit 4.14 .73 89 3.17 .94 240 -9.80 a 202.0 <.001 
   
 
  
    
Acupuncture          
 Credibility 3.99 .71 24 3.12 .81 299 -5.15 321 <.001 
 Effectiveness 3.94 .80 24 3.41 .65 299 -3.78 321 <.001 
 (Fewer) Concerns 3.878 .88 24 3.34 .80 299 -3.11 321 .002 
 Individual Fit 3.71 1.10 24 2.98 .83 299 -4.02 321 <.001 
a
 Equal variances not assumed 
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Table 6.  Measurement invariance of the LBP-TBQ for each treatment 
Treatment Nerve 
compression 
(present or 
absent) 
Sciatica 
(present or 
absent) 
Pain 
duration 
(<3yrs or 
≥ 3 yrs) 
Treatment 
experience 
(present or 
absent) 
Time (1st 
or 2nd 
survey) 
Medication None  Scalar Scalar NAa Scalar 
Exercise Scalar Scalar Scalar  Metric  Scalar 
Manual 
therapy 
Metric  Metric Scalar NAa Scalar 
Acupuncture Scalar None  Scalar None Scalar  
a NA = data not available due to low numbers of treatment naive patients. 
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Table 7.  4-item LBP-TBQ Scale and Item Homogeneity 
Content H (SE) 
 Pain 
medication 
Exercise Manual 
therapy 
Acupuncture 
Short form 0.43 (0.04) 0.58 
(0.04) 
0.66 
(0.03) 
0.61 (0.03) 
Taking/Having […] for back 
pain makes a lot of sense 
0.48 (0.04) 0.62 
(0.04) 
0.69 
(0.03) 
0.64 (0.04) 
I think […] is pretty useless for 
people with back pain (r) 
0.39 (0.04) 0.53 
(0.05) 
0. 64 
(0.04) 
0. 61 (0.04) 
I have concerns about 
taking/having […] for my back 
pain (r) 
0.37 (0.04) 0.56 
(0.04) 
0.63 
(0.03) 
0.56 (0.04) 
I am confident […] would be a 
suitable treatment for my back 
pain 
0.49 (0.04) 0.62 
(0.04) 
0.68 
(0.03) 
0.64 (0.03) 
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Table 8. 4-item LBP-TBQ: Means (M), Standard Deviations (SD), Stability and Cronbach α 
 
 Pain Medication Exercise Manual Therapy Acupuncture 
Scale/Item M(SD) α† Test-
retest 
M(SD) α† Test-
retest 
M(SD) α† Test-
retest 
M(SD) α† Test-
retest 
Short form 3.58 (0.75) .70  .82 3.63 (0.79) 81  .84 3.51 (0.84) .86  .85 3.19 (0.76) .83  .82 
Taking/Having […] for 
back pain makes a lot of 
sense 
3.75 (0.91) .60  3.86 (0.88) .74  3.67 (0.92) .80  3.21 (0.90) .76  
I think […] is pretty 
useless for people with 
back pain (r) 
3.98 (0.96) .67  3.99 (0.91) .79  3.86 (0.87) .83  3.43 (0.82) .78  
I have concerns about 
taking/having […] for my 
back pain (r) 
3.25 (1.21) .71  3.22 (1.15) .77  3.23 (1.17) .83  3.20 (1.06) .81  
I am confident […] would 
be a suitable treatment for 
my back pain 
3.34 (0.98) .59  3.45 (1.02) .73  3.30 (1.06) .80  2.94 (0.95) .76  
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Table 9.  4-item LBP-TBQ Criterion Validity  
 Group 1:  Treatment 
Ranked 1 
Group 2: Treatment 
Ranked 2-4 
Between-Group 
Comparison 
 M SD n M SD n t df p 
Medication  3.86 .62 152 3.41 .78 189 -5.78 339 <.001 
Exercise 4.07 .58 88 3.55 .81 239 -5.58 325 <.001 
Manual therapy 4.14 .71 89 3.30 .78 240 -9.25 a 171.02 <.001 
Acupuncture 3.83 .93 24 3.14 .73 299 -4.33 321 <.001 
a
 Equal variances not assumed 
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